Fennec Pharmaceuticals (TSX:FRX) Other Current Liabilities : C$-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Other Current Liabilities?

Fennec Pharmaceuticals's other current liabilities for the quarter that ended in Dec. 2023 was C$-0.00 Mil.

Fennec Pharmaceuticals's quarterly other current liabilities increased from Jun. 2023 (C$0.00 Mil) to Sep. 2023 (C$0.00 Mil) but then declined from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$-0.00 Mil).

Fennec Pharmaceuticals's annual other current liabilities stayed the same from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then declined from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$-0.00 Mil).

Fennec Pharmaceuticals Other Current Liabilities Historical Data

The historical data trend for Fennec Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Other Current Liabilities Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Fennec Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Fennec Pharmaceuticals Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.